Muestra la distribución de la producción WoS, Scopus y SciELO del autor.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
Firmas del autor | |
Nombre | BRANTES, SERGIO |
Género | Hombre |
Área Principal WOS | Medicine, General & Internal; Obstetrics & Gynecology; Endocrinology & Metabolism; |
Afiliación Principal | Universidad De Chile |
ORCID | 0000-0002-7729-3396 |
Publicaciones en Chile
Citas Totales
Afiliaciones Chilenas
WOS | #Pub |
---|---|
Medicine, General & Internal | 3 |
Obstetrics & Gynecology | 3 |
Endocrinology & Metabolism | 1 |
Scopus | #Pub |
---|---|
Medicine (All) | 3 |
Obstetrics And Gynecology | 2 |
SciELO | #Pub |
---|---|
Health Sciences | 4 |
Institución | # Pub |
---|---|
Universidad De Chile | 5 |
Hospital Del Salvador | 1 |
Sociedad Chilena De Arqueología | 1 |
Soc Chilena Climaterio | 1 |
Hosp Salvador | 1 |
Sociedad Chilena De Climaterio | 1 |
Año | Firma | Institución (Incites asoc.) | H Index | Average Percentile | Impact Citation | Impact Relative World | Impact Journal Normalized Citation | Impact Category Normalized Citation | Percentage Cited | Percentage Top 1 | Percentage Top 10 | Percentage Journal Q1 | Percentage Journal Q2 | Percentage Journal Q3 | Percentage Journal Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2019 | Brantes G, Sergio | Universidad de Chile | 0.0 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
2019 | Brantes Glavic, Sergio | Universidad de Chile | 0.0 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 0.0 |
2019 | Brantes, Sergio | Universidad de Chile | 1.0 | 90.7 | 3.0 | 0.3 | 0.8 | 0.1 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Palabra Clave | #Pub |
---|---|
menopause | 2 |
breast-cancer | 2 |
consensus | 2 |
osteoporosis | 2 |
diagnosis | 2 |
prevention | 1 |
metabolic syndrome x | 1 |
metastases | 1 |
models | 1 |
neoplasm metastasis | 1 |
photon | 1 |
position | 1 |
postmenopausal | 1 |
practice guideline | 1 |
prediction | 1 |
prevent fractures | 1 |
management | 1 |
recommendations | 1 |
risk | 1 |
score | 1 |
serum thyroglobulin | 1 |
symptoms | 1 |
thyroid neoplasms | 1 |
women's health initiative | 1 |
x-ray absorptiometry | 1 |
fine-needle | 1 |
antibodies | 1 |
aspiration biopsy | 1 |
biopsy | 1 |
carcinoma | 1 |
climacteric | 1 |
densitometry | 1 |
densitometty | 1 |
difference in restricted mean survival time | 1 |
dxa | 1 |
endometrial | 1 |
menopausal hormone therapy | 1 |
follow-up | 1 |
gonadal hormones | 1 |
guidelines | 1 |
hazard ratio | 1 |
hormone replacement therapy | 1 |
hormone-therapy | 1 |
life | 1 |
low-risk patients | 1 |
absorptiometry | 1 |
mean survival-time | 1 |